Registry for Evaluating Outcome of Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-01

Study Completion Date

2018-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Bernese-European RegistrY for ischemic stroke patients treated Outside current guidelines with Neurothrombectomy Devices using the SOLITAIRE™ FR With the Intention For Thrombectomy (BEYOND-SWIFT) is a retrospective, multi-center, non-randomized observational study aims to investigate the safety and efficacy of a Medtronic market-released neurothrombectomy device (applied as initial devices used for intervention) in acute ischemic stroke patients who do not fulfill treatment eligibility according to current guidelines. Patients will be treated or were treated at the discretion of the investigator, independent of participation in this registry. Primary Analysis is the Impact of successful reperfusion on functional outcome at day 90 in patients presenting with large infarct cores (ASPECTS\<6) or minor symptoms (NIHSS\<8).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry

NCT00811538

Ischemic Stroke

COMPLETED

Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy

NCT04620642

Ischemic Stroke

RECRUITING

PeRforation EVents During ENdovascular Therapy for Acute Ischemic Stroke

NCT06394180

Periprocedural Vessel Perforation Acute Ischemic Stroke

RECRUITING

Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy

NCT06034847

Stroke, Acute Thrombotic

NOT_YET_RECRUITING NA

Mechanical Thrombectomy Of Acute Occlusion In Ischemic Stroke

NCT03144960

Acute Stroke

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anterior circulation LVO patients with ASPECTS <6

Successful reperfusion

Intervention Type OTHER

Defined as modified Thrombolysis in Cerebral Infarction 2b/3

Anterior circulation LVO patients with NIHSS<8

No interventions assigned to this group

Posterior versus anterior circulation LVO patients

No interventions assigned to this group

LVO patients with isolated PCA or ACA occlusions

Successful reperfusion

Intervention Type OTHER

Defined as modified Thrombolysis in Cerebral Infarction 2b/3

Tandem lesions versus non-tandem lesion

No interventions assigned to this group

Bridging vs Direct MT

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Successful reperfusion

Defined as modified Thrombolysis in Cerebral Infarction 2b/3

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients or patient's legally authorized representative have given informed consent according to Good Clinical Practices (GCP) and/or IRB and/or local or institutional policies.
* The patient presents with an intracranial large vessel occlusion and therewith-related neurological symptoms and has been or will be treated with a Medtronic marketed-release neurothrombectomy device (applied as first device to attempt retrieving the thrombus).